← All companies
BridgeBio Pharma, Inc.
BBIO - Company ID 0001743881
Market cap$14.64 B
Rank#744
Filings770
Market capitalization of BridgeBio Pharma, Inc.
As of 2026-11-06, BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $14.64 B, making it the #744 most valuable US-listed company.
Recent market cap readings
| Date | Market cap |
|---|---|
| 2026-11-06 | $14.64 B |
| 2026-11-05 | $14.59 B |
| 2026-11-04 | $15.02 B |
| 2026-11-03 | $14.42 B |
| 2026-11-02 | $14.69 B |
| 2026-11-01 | $14.68 B |
| 2026-10-31 | $14.68 B |
| 2026-10-30 | $14.53 B |
| 2026-10-29 | $13.89 B |
| 2026-10-28 | $13.87 B |
| 2026-10-27 | $13.59 B |
| 2026-10-26 | $13.35 B |
Market Cap of similar companies
Frequently asked questions
What is BridgeBio Pharma, Inc.'s market cap?
As of 2026-11-06, BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $14.64 B, making it the #744 most valuable US-listed company.
Where does BridgeBio Pharma, Inc. rank by market cap?
BridgeBio Pharma, Inc. is the #744 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.